Sergey M. Kipriyanov

Author

Heidelberg University

Also Known As

S. M. Kipriyanov, S.M Kipriyanov, S.M. Kipriyanov, Sergey Kipriyanov, Sergey M Kipriyanov, Sergey M. Kipriyanov

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University German Cancer Research Center Affimed Therapeutics (Germany)DKFZ-ZMBH Alliance Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK)

About

Sergey M. Kipriyanov is an author at Heidelberg University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.1K
2	Natural Sciences	4	4	139
3	Allergy	4	4	317
4	Engineering	2	2	220
5	Biochemistry	1	1	79

Sergey M. Kipriyanov

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
High level production of soluble single chain antibodies in small-scale Escherichia coli cultures Sergey M. Kipriyanov, Gerhard Moldenhauer, Melvyn Little Journal of Immunological Methods High Level ProductionEngineeringBacteriologyBiotechnologySynthetic Biology	1997	202
Di‐, tri‐ and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding Fabrice Le Gall, Sergey M. Kipriyanov, Gerhard Moldenhauer, FEBS Letters B-cell MalignanciesCell-bound AntigenImmunologyImmunodominanceImmunologic Mechanism	1999	127
Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity Sergey M. Kipriyanov, Gerhard Moldenhauer, Andrew C.R. Martin, Protein Engineering Design and Selection Amino Acid MutationsHumoral ResponseImmunologyImmunodominanceImmunologic Mechanism	1997	125
The antigen-binding domain of a human IgG-anti-F(ab′)<sub>2</sub> autoantibody Martin Welschof, Peter Terness, Sergey M. Kipriyanov, Proceedings of the National Academy of Sciences	1997	100
Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma Sergey M. Kipriyanov, Björn Cochlovius, Holger Schäfer, The Journal of Immunology	2002	90
Bispecific CD3 × CD19 diabody for T cell-mediated lysis of malignant human B cells Sergey M. Kipriyanov, Gerhard Moldenhauer, Melvyn Little International Journal of Cancer ImmunologyImmunologic MechanismAntigen ProcessingCd4 T Cell ResponsesImmunotherapy	1998	89
Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment–core streptavidin fusion Sergey M. Kipriyanov, Melvyn Little, Harald Kropshofer, Protein Engineering Design and Selection	1996	87
A Bispecific Diabody That Mediates Natural Killer Cell Cytotoxicity Against Xenotransplantated Human Hodgkin’s Tumors Michaela A.E. Arndt, Sergey M. Kipriyanov, Michael Pfreundschuh, Blood	1999	84
Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody Fabrice Le Gall, Uwe Reusch, Melvyn Little, Protein Engineering Design and Selection	2004	80
Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: Production of bivalent and biotinylated miniantibodies Sergey M. Kipriyanov, Stefan Dübel, Frank Breitling, Molecular Immunology BiochemistryProtein FoldingNatural SciencesBioconjugationMolecular Biology	1994	79

Page 1